AU2001256745A1 - Vector for analysing replication mechanism of rna virus and use thereof - Google Patents

Vector for analysing replication mechanism of rna virus and use thereof

Info

Publication number
AU2001256745A1
AU2001256745A1 AU2001256745A AU5674501A AU2001256745A1 AU 2001256745 A1 AU2001256745 A1 AU 2001256745A1 AU 2001256745 A AU2001256745 A AU 2001256745A AU 5674501 A AU5674501 A AU 5674501A AU 2001256745 A1 AU2001256745 A1 AU 2001256745A1
Authority
AU
Australia
Prior art keywords
analysing
vector
rna virus
replication mechanism
replication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001256745A
Inventor
Asao Katsume
Michinori Kohara
Junichi Matsuzaki
Kouichi Okamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Tokyo Metropolitan Organization for Medical Research
Original Assignee
TOKYO METROPOLITAN ORG MED RES
Chugai Pharmaceutical Co Ltd
Tokyo Metropolitan Organization for Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TOKYO METROPOLITAN ORG MED RES, Chugai Pharmaceutical Co Ltd, Tokyo Metropolitan Organization for Medical Research filed Critical TOKYO METROPOLITAN ORG MED RES
Publication of AU2001256745A1 publication Critical patent/AU2001256745A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/127—RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001256745A 2000-05-15 2001-05-15 Vector for analysing replication mechanism of rna virus and use thereof Abandoned AU2001256745A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-142451 2000-05-15
JP2000142451 2000-05-15
PCT/JP2001/004033 WO2001088161A1 (en) 2000-05-15 2001-05-15 Vector for analysing replication mechanism of rna virus and use thereof

Publications (1)

Publication Number Publication Date
AU2001256745A1 true AU2001256745A1 (en) 2001-11-26

Family

ID=18649420

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001256745A Abandoned AU2001256745A1 (en) 2000-05-15 2001-05-15 Vector for analysing replication mechanism of rna virus and use thereof

Country Status (4)

Country Link
US (1) US20030143528A1 (en)
EP (1) EP1283267A4 (en)
AU (1) AU2001256745A1 (en)
WO (1) WO2001088161A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1090996A4 (en) * 1998-06-24 2003-03-26 Chugai Pharmaceutical Co Ltd Vector expressing the full-length gene of rna virus and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4594996A (en) * 1994-11-30 1996-06-19 Chiron Viagene, Inc. Recombinant alphavirus vectors
AU6904596A (en) * 1995-09-13 1997-04-01 Chiron Corporation Method and construct for screening for inhibitors of transcriptional activation
JP3831035B2 (en) * 1996-12-13 2006-10-11 財団法人化学及血清療法研究所 Hepatitis C virus sensitive recombinant hepatocytes and use thereof
EP1068362A4 (en) * 1998-04-02 2005-07-20 Viropharma Inc Hepatitis c virus ns5b compositions and methods of use thereof
EP1090997A4 (en) * 1998-06-24 2002-07-03 Int Reagents Corp Hcv-derived rna polymerase gene

Also Published As

Publication number Publication date
EP1283267A4 (en) 2004-05-12
US20030143528A1 (en) 2003-07-31
WO2001088161A1 (en) 2001-11-22
EP1283267A1 (en) 2003-02-12

Similar Documents

Publication Publication Date Title
AU2001278076A1 (en) Bstp-5 proteins and related reagents and methods of use thereof
AU2001241474A1 (en) Biosensor compositions and methods of use
AU2001285020A1 (en) P97-active agent conjugates and their methods of use
AU2002320058A1 (en) Magnetic-nanoparticle conjugates and methods of use
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002314466A1 (en) Withasol and methods of use
AU2001281850A1 (en) Use of inulin and inulin derivatives
AU2002211736A1 (en) Methods for synthesizing precipitated silica and use thereof
AU2001278011A1 (en) Bstp-ecg1 protein and related reagents and methods of use thereof
AU2001288972A1 (en) Antipsychotic sulfonamide-heterocycles, and methods of use thereof
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2002214477A1 (en) Modified nucleosides and nucleotides and use thereof
AU2001293048A1 (en) Antiviral compositions and methods of use
AU2001247196A1 (en) Methods and compositions for detection of disease
AU2001256745A1 (en) Vector for analysing replication mechanism of rna virus and use thereof
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2000239273A1 (en) Systems and methods of viral marketing
AU2001270908A1 (en) Methods for detection of human papillomavirus mrna
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU2001268236A1 (en) Use of aicar and related compounds
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2001265280A1 (en) Preparation of 2-hydroxy-5-oxoproline and analogs thereof
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
AUPQ760400A0 (en) Herbical formulations and methods of use thereof
AU2002213145A1 (en) Detection and quantification of human herpes viruses